Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide analyses and functional profiling of human NK cell lines
Justin T. Gunesch, Laura S. Angelo, Sanjana Mahapatra, et al.
Molecular Immunology (2018) Vol. 115, pp. 64-75
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
Karama Makni‐Maalej, Maysaloun Merhi, Varghese Inchakalody, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 292
Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
Erica L. Heipertz, Evan R. Zynda, Tor Espen Stav-Noraas, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 127
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 82
CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
Yaxian Kong, Jingyao Li, Xia Zhao, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3
Immunoregulatory functions and therapeutic potential of natural killer cell-derived extracellular vesicles in chronic diseases
Shuang He, Lanqian Su, Haiyang Hu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 11
CD56 regulates human NK cell cytotoxicity through Pyk2
Justin T. Gunesch, Amera L. Dixon, Tasneem Ebrahim, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 53
Therapeutic effect of small extracellular vesicles from cytokine-induced memory-like natural killer cells on solid tumors
Ying‐Hong Shi, Yanxia Chen, Yi Wang, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
Lydia T Navarrete-Galvan, Michael Guglielmo, Judith Cruz Amaya, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Degranulation enhances presynaptic membrane packing, which protects NK cells from perforin-mediated autolysis
Yu Li, Jordan S. Orange
PLoS Biology (2021) Vol. 19, Iss. 8, pp. e3001328-e3001328
Open Access | Times Cited: 28
Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity
Linnea Kristenson, Chiara Badami, Angelica Ljungberg, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 15
Open Access | Times Cited: 4
The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicity
Luis Alberto Pedroza, Frederique van den Haak, Alexander Frumovitz, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115156-115156
Open Access
Research Progress of NK Cells in Glioblastoma Treatment
Hao Wu, Qi Liu, Fenglu Wang, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 87-106
Open Access
ADCC: the rock band led by therapeutic antibodies, tumor and immune cells
Roos Vincken, Uxue Armendáriz-Martínez, Ana Ruiz-Sáenz
Frontiers in Immunology (2025) Vol. 16
Open Access
Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2
Prabha Shrestha, David A. Davis, Hannah K. Jaeger, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 1, pp. e1009091-e1009091
Open Access | Times Cited: 24
Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment
Natasha Mupeta Kaweme, Fuling Zhou
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Cancer immunity by tissue‐resident type 1 innate lymphoid cells and killer innate‐like T cells
Jing Zhang, Albert M. Li, Emily R. Kansler, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 150-163
Open Access | Times Cited: 3
Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review)
Yongqin Zeng, Xiuzhi Lv, Juan Du
Oncology Reports (2021) Vol. 46, Iss. 5
Open Access | Times Cited: 23
The Lysosomal Calcium Channel TRPML1 Maintains Mitochondrial Fitness in NK Cells through Interorganelle Cross-Talk
Dennis Clement, Edina K. Szabo, Silje Zandstra Krokeide, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 9, pp. 1348-1358
Open Access | Times Cited: 9
A Hot Topic: Cancer Immunotherapy and Natural Killer Cells
Tatiana Michel, Markus Ollert, Jacques Zimmer
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 797-797
Open Access | Times Cited: 14
Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy
Hyun Gul Yang, Moon Cheol Kang, Tae Yoon Kim, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 21
Fc γ receptor IIIa/CD16a processing correlates with the expression of glycan-related genes in human natural killer cells
Kashyap Patel, María C. Rodríguez, W. Walter Lorenz, et al.
Journal of Biological Chemistry (2020) Vol. 296, pp. 100183-100183
Open Access | Times Cited: 19
Humanized Mouse Models for the Advancement of Innate Lymphoid Cell-Based Cancer Immunotherapies
Nina B. Horowitz, Imran Mohammad, Uriel Y. Moreno‐Nieves, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
β-Actin G342D as a Cause of NK Cell Deficiency Impairing Lytic Synapse Termination
Abigail E. Reed, Jackeline Peraza, Frederique van den Haak, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 6, pp. 962-973
Open Access | Times Cited: 2
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia
Yuta Kaito, Yoichi Imai
International Journal of Hematology (2024) Vol. 120, Iss. 1, pp. 34-43
Closed Access | Times Cited: 2
Replication Stress in Activated Human NK Cells Induces Sensitivity to Apoptosis
Nicole C. Guilz, Yong‐Oon Ahn, Hijab Fatima, et al.
The Journal of Immunology (2024) Vol. 213, Iss. 1, pp. 40-51
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top